Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Targeting the secretory pathway for anti-inflammatory drug development.

Ludwig JW, Richards ML.

Curr Top Med Chem. 2006;6(2):165-78. Review.

PMID:
16454765
2.

Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?

Russo RC, Garcia CC, Teixeira MM.

Curr Opin Drug Discov Devel. 2010 Jul;13(4):414-27. Review.

PMID:
20597027
3.

Update on statin-mediated anti-inflammatory activities in atherosclerosis.

Montecucco F, Mach F.

Semin Immunopathol. 2009 Jun;31(1):127-42. doi: 10.1007/s00281-009-0150-y. Epub 2009 May 5. Review.

PMID:
19415282
4.

Anti-inflammatory drugs in the 21st century.

Rainsford KD.

Subcell Biochem. 2007;42:3-27. Review.

PMID:
17612044
5.

Inhibitory receptors on myeloid cells: new targets for therapy?

Munitz A.

Pharmacol Ther. 2010 Jan;125(1):128-37. doi: 10.1016/j.pharmthera.2009.10.007. Epub 2009 Nov 11. Review.

PMID:
19913051
6.

PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies.

Harris SJ, Foster JG, Ward SG.

Curr Opin Investig Drugs. 2009 Nov;10(11):1151-62. Review.

PMID:
19876783
7.

Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.

Motilva V, Talero E, Calvo JR, Villegas I, Alarcón-de-la-Lastra C, Sánchez-Fidalgo S.

Curr Pharm Des. 2008;14(1):71-95. Review.

PMID:
18220820
8.

Proximal signaling molecules as potential targets for anti-inflammatory therapy.

Löwenberg M.

Curr Opin Drug Discov Devel. 2007 Sep;10(5):560-4. Review.

PMID:
17786854
9.

Emerging drugs for asthma.

Walsh GM.

Expert Opin Emerg Drugs. 2008 Dec;13(4):643-53. doi: 10.1517/14728210802591378 . Review. Erratum in: Expert Opin Emerg Drugs. 2009 Mar;14(1):205.

PMID:
19046132
10.

Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects in vivo.

Grainger DJ, Reckless J.

Biochem Pharmacol. 2003 Apr 1;65(7):1027-34. Review.

PMID:
12663038
11.

Drug discovery for inflammatory diseases.

Rogatsky I.

Expert Opin Biol Ther. 2003 Sep;3(6):1001-4. Review.

PMID:
12943459
12.

Evidence for Golgi-independent transport from the early secretory pathway to the plastid in malaria parasites.

Tonkin CJ, Struck NS, Mullin KA, Stimmler LM, McFadden GI.

Mol Microbiol. 2006 Aug;61(3):614-30. Epub 2006 Jun 20.

13.

Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

Gonzalez-Rey E, Delgado M.

Trends Pharmacol Sci. 2007 Sep;28(9):482-91. Epub 2007 Aug 3. Review.

PMID:
17688953
14.

Targeting signal transduction as a strategy to treat inflammatory diseases.

O'Neill LA.

Nat Rev Drug Discov. 2006 Jul;5(7):549-63. Epub 2006 Jun 9. Review.

PMID:
16773072
15.

Novel targets for antiinflammatory and antiarthritic agents.

Kulkarni RG, Achaiah G, Sastry GN.

Curr Pharm Des. 2006;12(19):2437-54. Review.

PMID:
16842190
16.

Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane.

Farhan H, Freissmuth M, Sitte HH.

Handb Exp Pharmacol. 2006;(175):233-49. Review.

PMID:
16722239
17.

Control of chronic inflammation with pathway selective estrogen receptor ligands.

Steffan RJ, Matelan E, Ashwell MA, Moore WJ, Solvibile WR, Trybulski E, Chadwick CC, Chippari S, Kenney T, Winneker RC, Eckert A, Borges-Marcucci L, Adelman SJ, Xu Z, Mosyak L, Harnish DC.

Curr Top Med Chem. 2006;6(2):103-11. Review.

PMID:
16454762
18.

Targeting airway inflammation: novel therapies for the treatment of asthma.

Walsh GM.

Curr Med Chem. 2006;13(25):3105-11. Review.

PMID:
17073650
19.

Carbon monoxide-releasing molecules: a pharmacological expedient to counteract inflammation.

Alcaraz MJ, Guillen MI, Ferrandiz ML, Megías J, Motterlini R.

Curr Pharm Des. 2008;14(5):465-72.

PMID:
18289073
20.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk